Skip to main content
Log in

Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Colchicine and statins are well known drugs that cause myopathy and neuropathy. Co-administration of certain drugs with statins may increase myotoxic effect, causing myopathy and varying degrees of rhabdomyolysis. Therefore, it is very crucial to know which statin should be used during a combination therapy including colchicine and other drugs. We present three cases with AA amyloidosis secondary to familial Mediterranean fever, who developed neuromyopathy while receiving the combination of colchicine and statin. We also briefly discussed the different metabolic pathways of statins and colchicine when used together.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ensari C, Ensari A, Tumer N, Ertug E (2005) Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients. Nephrol Dial Transplant 20:1721–1725

    Article  PubMed  Google Scholar 

  2. Tunca M, Akar S, Onen F et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11

    Article  Google Scholar 

  3. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 314:1001–1005

    Article  CAS  Google Scholar 

  4. Toto RD, Grundy SM, Vega GL (2000) Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome. Am J Nephrol 20:12–17

    Article  PubMed  CAS  Google Scholar 

  5. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M (1987) Colchicine myopathy and neuropathy. N Engl J Med 316:1562–1568

    Article  PubMed  CAS  Google Scholar 

  6. Uçar M, Mjorndal T, dahlqvist R (2000) HMG-CoA reductase inhibitors and myotoxicity. Drug Saf 22:441–457

    Article  PubMed  Google Scholar 

  7. Omar MA, Wilson JP, Cox TS (2001) Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother 35:1096–1107

    Article  PubMed  CAS  Google Scholar 

  8. Roten L, Schoenenberger RA, Krahenbuhl S, Schlienger RG (2004) Rhabdomyolysis in association with simvastatin and amiodarone. Ann Pharmacother 38:978–981

    Article  PubMed  Google Scholar 

  9. Lee AJ, Maddix DS (2001) Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. Ann Pharmacother 35:26–31

    Article  PubMed  CAS  Google Scholar 

  10. Shaukat A, Benekli M, Vladutiu GD, Slack JL, Wetzler M, Baer MR (2003) Simvastatin-fluconazole causing rhabdomyolysis. Ann Pharmacother 37:1032–1035

    Article  PubMed  Google Scholar 

  11. Tateishi T, Soucek P, Caraco Y et al (1998) Colchicine-induced myopathy with myotonia. Muscle Nerve 21:550–551

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cengiz Korkmaz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sahin, G., Korkmaz, C. & Yalcin, A.U. Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis. Rheumatol Int 28, 289–291 (2008). https://doi.org/10.1007/s00296-007-0435-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0435-1

Keywords

Navigation